Anti-B7-H5 antibodies and their uses
US10316092B2 · kind B2 · utility
2Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 27, 2014 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Aug 24, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies and their antigen-binding fragments and to other molecules that are capable of immunospecifically binding to the B7-H5 ligand of the B7-H5:CD28H pathway, and to the uses of such molecules in the treatment and diagnosis of autoimmune disease, transplant rejection and other inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.